Wendella69, Inc., f/k/a Southwest Florida Veterinary Specialists, Inc.; Wendy G. Arsenault; and Michael J. Arsenault v. PetVet Operating, LLC, f/k/a PetVet Care Centers (Florida), LLC

CourtDistrict Court, M.D. Florida
DecidedOctober 24, 2025
Docket2:22-cv-00539
StatusUnknown

This text of Wendella69, Inc., f/k/a Southwest Florida Veterinary Specialists, Inc.; Wendy G. Arsenault; and Michael J. Arsenault v. PetVet Operating, LLC, f/k/a PetVet Care Centers (Florida), LLC (Wendella69, Inc., f/k/a Southwest Florida Veterinary Specialists, Inc.; Wendy G. Arsenault; and Michael J. Arsenault v. PetVet Operating, LLC, f/k/a PetVet Care Centers (Florida), LLC) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Wendella69, Inc., f/k/a Southwest Florida Veterinary Specialists, Inc.; Wendy G. Arsenault; and Michael J. Arsenault v. PetVet Operating, LLC, f/k/a PetVet Care Centers (Florida), LLC, (M.D. Fla. 2025).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA FORT MYERS DIVISION

WENDELLA69, INC., f/k/a SOUTHWEST FLORIDA VETERINARY SPECIALISTS INC.; WENDY G. ARSENAULT; and MICHAEL J. ARSENAULT,

Plaintiffs,

v. Case No: 2:22-cv-539-JES-KCD

PETVET OPERATING, LLC, f/k/a PETVET CARE CENTERS (FLORIDA), LLC,

Defendant.

OPINION AND ORDER This matter comes before the Court on defendant’s Amended Motion to Dismiss Count I of Plaintiffs’ Second Amended Complaint. (Doc. #148). Plaintiffs filed a Response in Opposition. (Doc. #150.) Also before the Court are Responses (Docs. ##152, 153) to the Court’s Order to Show Cause (Doc. #151.) For the reasons set forth below, the motion is granted and Count I of the Second Amended Complaint (Doc. #146) is dismissed without prejudice. I. The Second Amended Complaint and documents the Court may consider at the motion to dismiss stage of the proceedings establish the following: The parties are Plaintiffs Wendella69, Inc. (f/k/a/ SW. Fla. Veterinary Specialists, Inc.), Wendy G. Arsenault, and Michael J. Arsenault (collectively “Sellers” or plaintiffs) and Defendant PetVet Operating, LLC (f/k/a PetVet Care Centers (Fla.), LLC)

(“Buyer”, PetVet or defendant). On December 24, 2019, Sellers sold their veterinary practice (the “Business”) to Buyer pursuant to an Asset Purchase Agreement (the “Agreement”). Exhibit A of the Agreement (Exhibit A) provides that, in addition to substantial payments due at Closing, the Buyer may be obligated to pay an “Earnout Payment” at the end of a two year “Earnout Period.” This essentially provided Sellers an additional two years after Closing for the Business’s sales price to increase. (Doc. #53-1, p. 35.) The Earnout Payment was to be calculated by a formula that subtracted “Target EBITDA” from “EBITDA” at the end of the Earnout Period and multiplied the result by five. (Id.) Thus, if the EBITDA exceeded the Target EBITDA, Buyer was required to pay Seller

an additional amount (the “Earnout Payment”) equal to the EBITDA, minus the Target EBITDA, multiplied by five. (Earnout Payment = (EBITDA – Target EBITDA) X 5). If there was a disagreement over the Earnout Payment, Exhibit A provided a detailed, multi-step dispute resolution process. (Id. at p. 35.) Step One required Buyer to deliver its EBITDA determination to Sellers “no later than sixty (60) days after the end of the Earnout Period.” (Id.) Step Two allowed Sellers “reasonable access” to Buyers’ books and records “relating to the calculation of EBITDA,” but only “during regular business hours” and only “for the sole purpose of verifying Buyer’s computations of the EBITDA.” (Id.) Step Three gave Sellers “thirty (30) days”

after receiving Buyers’ EBITDA determination to submit a “Notice of Disagreement” should they “disagree[] in good faith with Buyer’s determination of EBITDA.” (Id.) The Notice of Disagreement was required to “set forth in reasonable detail the basis for the disagreement.” (Id.) Step Four required that Sellers and Buyer “shall attempt in good faith to resolve and finally determine the amount of EBITDA.” (Id.) Step Five provided that if Sellers and Buyer could not resolve their disagreement within “fifteen (15) days” after Buyer’s receipt of the Notice of Disagreement, “the parties shall retain the services of [a] Neutral Auditor to resolve the disagreement and make a determination with respect thereto.” (Id.)

Section (g) of Exhibit A defined “Neutral Auditor” as “an independent accounting firm selected by Buyer which does not have a material relationship with Buyer or Seller.” (Id.) Section (d) of Exhibit A provided: . . . The Neutral Auditor shall then determine the EBITDA and such determination by the Neutral Auditor shall be binding upon the parties hereto, provided, however, that EBITDA determined by the Neutral Auditor shall be no greater than EBITDA determined by Seller and no less than EBITDA determined by Buyer. The determination of the Neutral Auditor shall be made as an expert and not as an arbiter and shall be based solely on the written submissions by Buyer and Seller and their respective representatives and any other communication requested by the Neutral Auditor, and the determination shall not be by independent review. Buyer and Seller shall use their commercially reasonable efforts to cause the Neutral Auditor to complete its review thereof within fifteen (15) days of its appointment. If such a review by a Neutral Auditor is conducted, then the party (i.e., Buyer, on the one hand, or Seller, on the other hand) whose calculation of EBITDA is furthest from EBITDA determined by the Neutral Auditor shall pay all fees and expenses of the Neutral Auditor associated with such review.

(Id.) Section (d) closes with the parties’ agreement that the Auditor’s “determination . . . shall be conclusive, final and binding.” (Id.) On March 25, 2022, Buyer delivered its EBITDA determination to Sellers. (Doc. #148, p. 4, citing Doc. #146, ¶ 22.) Within thirty days, Sellers sent Buyer a Notice of Disagreement. (Doc. #1-3.) The Notice of Disagreement stated that Sellers “do not agree with the EBITDA calculation” and set forth the Sellers’ reasons. Buyer and Sellers did not resolve their disagreement within fifteen days, and Buyer selected a Neutral Auditor. (Doc. #148, p. 4.) On July 26, 2022, prior to any determination by the Neutral Auditor, Sellers filed a Complaint in state court (Doc. #1-2), which Buyer timely removed to federal court based on the complete diversity of citizenship. (Doc. #1, ¶¶ 3–4; Doc. #1-2, p. 58.) Because of the pending lawsuit, the Neutral Auditor never rendered a determination of the EBITDA or Earnout Payment. (Doc. #146, ¶ 41, Doc. #148, p. 3.) In due course Buyer filed its Answer and Affirmative Defenses to that Complaint. (Doc. #24.) In its Third and Fourth Affirmative Defenses, Buyer asserted that:

The Complaint is subject to dismissal for improper venue, and Plaintiffs are not entitled to any relief because the [Agreement] provides that the “determination of the Neutral Auditor shall be conclusive, final and binding upon the parties.”

[ . . . ]

Plaintiffs are not entitled to any relief in this action because they have failed to satisfy conditions precedent to commencing this action, including complying with and exhausting the dispute resolution procedures set forth in Section 7.15 of the [Agreement], and, to the extent that the audit process set forth in the [Agreement] is reviewable by the Court, completing the same. Therefore, Plaintiffs’ claims are not ripe for adjudication.

(Id. at 8.) On October 4, 2023, Buyer filed a sealed motion for judgment on the pleadings, asserting that Sellers “are barred from adjudicating, in this Court, any claim that [Buyer] improperly calculated EBITDA or the Earnout Payment and seeking damages based on any alleged difference between [Sellers’] and [Buyer]’s calculations.” (Doc. #53, p. 2.) The Court ultimately denied the motion, concluding that the case as pled in the original Complaint was only a “books and records” dispute and lacked any “allegations challenging the determination of EBITDA.” (Doc. #123, pp. 8–9.) A settlement conference held on December 2, 2024, was unsuccessful. (Docs. ##126, 134.) Sellers thereafter filed an Amended Complaint (Doc. #144), which was superseded by the now-operative Second Amended Complaint (“SAC”) (Doc. #146.) The SAC contains two counts, both alleging

breach of contract.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Libeau v. Fox
880 A.2d 1049 (Court of Chancery of Delaware, 2005)
Libeau v. Fox
892 A.2d 1068 (Supreme Court of Delaware, 2006)
Nemec v. Shrader
991 A.2d 1120 (Supreme Court of Delaware, 2010)
Krahmer v. Christie's, Inc.
906 A.2d 806 (Supreme Court of Delaware, 2006)
Melanie L. Garcia v. Wells Fargo Bank, NA
889 F.3d 1230 (Eleventh Circuit, 2018)
Viacom International Inc. v. Winshall
72 A.3d 78 (Supreme Court of Delaware, 2013)
Isaac Payne v. Savannah College of Art and Design, Inc.
81 F.4th 1187 (Eleventh Circuit, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
Wendella69, Inc., f/k/a Southwest Florida Veterinary Specialists, Inc.; Wendy G. Arsenault; and Michael J. Arsenault v. PetVet Operating, LLC, f/k/a PetVet Care Centers (Florida), LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/wendella69-inc-fka-southwest-florida-veterinary-specialists-inc-flmd-2025.